All Stories

  1. Real-world Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Mellitus During the Period of Ramadan in Four Countries (Egypt, Jordan, Lebanon, and Turkey): A Prospective Observational Study

    Article • Current Diabetes Reviews, May 2024, Bentham Science Publishers

    Dr Mohamed M Hassanein, Hajar Ballout

  2. Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)

    Article • International Journal of Clinical Practice, August 2017, Wiley

    Dr Mohamed M Hassanein

  3. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates

    Article • International Journal of Clinical Practice, September 2016, Wiley

    Dr Mohamed M Hassanein

  4. Multi‐country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 ( CREED )

    Article • Diabetic Medicine, April 2015, Wiley

    Dr Mohamed M Hassanein

  5. A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study

    Article • Vascular Health and Risk Management, May 2014, Taylor & Francis

    Dr Mohamed M Hassanein

  6. Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice

    Article • Indian Journal of Endocrinology and Metabolism, January 2014, Medknow

    Dr Mohamed M Hassanein